Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Clinical parameters related to metamorphopsia outcome in patients with resolved central serous chorioretinopathy using M-CHARTS: retrospective cohort study

Fig. 1

Scattergrams showing correlations between metamorphopsia severity and clinical parameters including symptom duration (a), final central foveal thickness (CFT) (b) and final thickness of outer nuclear layer (ONL) (c) for the 36 total study eyes with resolved central serous chorioretinopathy. The metamorphopsia severity was evaluated by averaging the vertical and horizontal M-CHARTS scores. The M-CHARTS scores showed significant correlation with symptom duration (ρ = 0.517, P = 0.001), final CFT (ρ = −0.383, P = 0. 021) and final thickness of ONL (ρ = −0.372, P = 0.025)

Back to article page